1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-108847 Etanercept

TNF Receptor

Inflammation/Immunology

2020-05 Etanercept
HY-111226A (E/Z)-GSK5182

Estrogen Receptor/ERR; Reactive Oxygen Species

Cancer;

Cardiovascular Disease

2020-05 (E/Z)-GSK5182
HY-136362 c-Fms-IN-12

c-Fms

Cancer;

Inflammation/Immunology

2020-05 c-Fms-IN-12
HY-12554A Terlipressin acetate

Vasopressin Receptor

Cardiovascular Disease;

Endocrinology;

Inflammation/Immunology

2020-05 Terlipressin acetate
HY-P0175A 740 Y-P TFA

PI3K

Cancer

2020-05 740 Y-P TFA
HY-136103 DBCO-PEG4-Propionic-Val-Cit-PAB

ADC Linker

Cancer

2020-05 DBCO-PEG4-Propionic-Val-Cit-PAB
HY-136087 Mal-bis-PEG3-DBCO

ADC Linker

Cancer

2020-05 Mal-bis-PEG3-DBCO
HY-P1791B Lactoferrin (17-41) (acetate)

Bacterial; Fungal; Apoptosis

Cancer;

Infection

2020-05 Lactoferrin (17-41) (acetate)
HY-W012658 2-Methylacetophenone

Endogenous Metabolite

Metabolic Disease

2020-05 2-Methylacetophenone
HY-W041470 4-Methyl-1-phenyl-2-pentanone

Metabolic Disease

2020-05 4-Methyl-1-phenyl-2-pentanone
HY-136074 Methyltetrazine-PEG4-aldehyde

ADC Linker

Cancer

2020-05 Methyltetrazine-PEG4-aldehyde
HY-Y0442 2-Methylbenzaldehyde

Metabolic Disease

2020-05 2-Methylbenzaldehyde
HY-Y1366 Hydroxyacetone

Endogenous Metabolite

Metabolic Disease

2020-05 Hydroxyacetone
HY-W018197 2-Phenylacetamide

Metabolic Disease

2020-05 2-Phenylacetamide
HY-W019151 Meconine

Metabolic Disease

2020-05 Meconine
HY-W009516 Dibenzyl disulfide

Metabolic Disease

2020-05 Dibenzyl disulfide
HY-136098 DBCO-PEG4-acetic-Val-Cit-PAB

ADC Linker

Cancer

2020-05 DBCO-PEG4-acetic-Val-Cit-PAB
HY-W012860 p-Tolualdehyde

Endogenous Metabolite

Metabolic Disease

2020-05 p-Tolualdehyde
HY-W004874 2,6-Dimethylhydroquinone

Metabolic Disease

2020-05 2,6-Dimethylhydroquinone
HY-136095 Tetrazine-biotin

ADC Linker

Cancer

2020-05 Tetrazine-biotin